ProShares UltraShort Health Care
3 hedge funds and large institutions have $229K invested in ProShares UltraShort Health Care in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
77% more capital invested
Capital invested by funds: $130K → $229K (+$99.5K)
3.33% more ownership
Funds ownership: 7.16% → 10.49% (+3.3%)
25% less funds holding
Funds holding: 4 → 3 (-1)
30% less call options, than puts
Call options by funds: $7.46M | Put options by funds: $10.7M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$134K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$20 |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11 |
RXD Hedge Fund Activity: Q4 2025 in Review
3 of the 7,918 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q4 2025, worth a combined $229K — up 77% from $130K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RXD and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Susquehanna International Group, adding an estimated $134K. The largest seller was Morgan Stanley, cutting an estimated $20.
- 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q4 2025, down from 4 in Q3 2025.
- Funds reported $229K of ProShares UltraShort Health Care stock for Q4 2025, up 77% quarter-over-quarter.
- 0 funds opened new ProShares UltraShort Health Care positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest ProShares UltraShort Health Care buyer in Q4 2025 was Susquehanna International Group, an estimated $134K added.
- The largest ProShares UltraShort Health Care seller in Q4 2025 was Morgan Stanley, an estimated $20 sold.
Based on aggregated 13F filings for Q4 2025.